Literature DB >> 3547056

Subtype-specific identification of influenza virus in cell cultures with FITC labelled egg yolk antibodies.

P C Döller, G Döller, H J Gerth.   

Abstract

We report on results obtained with a direct immunofluorescence test for subtype-specific identification of influenza virus in detached cells of MDCK cultures after inoculation of 281 clinical specimens from patients with influenza-like disease. Influenza virus antibodies were produced in eggs from immunized hens and labelled with FITC. In 157 cases CPE was found in MDCK cells. A total of 57 cases of influenza A (H3N2), 86 cases of influenza A (H1N1), and 14 cases of influenza B were identified. In 33 cases of influenza A (H1N1) infection with massive CPE guinea pig but not chicken erythrocytes were agglutinated by the cell culture supernatants. The single step immunofluorescence test described proved easy to perform and results were obtained within 1 h after CPE was observed in contrast to the conventional HIT which is very time-consuming.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3547056     DOI: 10.1007/BF00189406

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence.

Authors:  E T Gamboa; A Wolf; M D Yahr; D H Harter; P E Duffy; H Barden; K C Hsu
Journal:  Arch Neurol       Date:  1974-10

2.  [Rapid diagnosis of influenza by the method of indirect fluorescence staining].

Authors:  L Hercik; D Procházka
Journal:  Zentralbl Bakteriol Orig       Date:  1969

3.  Rapid diagnosis of influenza B with fluorescent antibody.

Authors:  I T Ebisawa; M Makino; Y Takeuchi
Journal:  Jpn J Exp Med       Date:  1966-06

4.  Rapid method of extraction of antibodies from hen egg yolk.

Authors:  H Bade; H Stegemann
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

5.  Evaluation of a solid-phase immunoassay with fluorescein isothiocyanate-conjugated heterogeneous or monoclonal antibodies for identification of virus isolates, with influenza virus as a model.

Authors:  D J Phillips; G G Galland; C B Reimer; A P Kendal
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

6.  Early detection of influenza virus in cell culture by means of immunofluorescence.

Authors:  A F Rahman
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

7.  Individuals infected with two subtypes of influenza A virus in the same season.

Authors:  A L Frank; L H Taber; J M Wells
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

8.  Seroepidemiology of H1N1 influenza: the range of the affected population is widening.

Authors:  R Pyhälä; K Aho
Journal:  Med Biol       Date:  1982-12

9.  Virological, immunochemical, and cytochemical studies of four HeLa cell lines infected with two strains of influenza virus.

Authors:  V Ter Meulen; R Love
Journal:  J Virol       Date:  1967-06       Impact factor: 5.103

10.  Isolation of viral IgY antibodies from yolks of immunized hens.

Authors:  A Polson; M B von Wechmar; M H van Regenmortel
Journal:  Immunol Commun       Date:  1980
View more
  3 in total

1.  Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding.

Authors:  G Döller; W Schuy; K Y Tjhen; B Stekeler; H J Gerth
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay.

Authors:  T Ziegler; H Hall; A Sánchez-Fauquier; W C Gamble; N J Cox
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

3.  A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site.

Authors:  I Günther; B Glatthaar; G Döller; W Garten
Journal:  Virus Res       Date:  1993-02       Impact factor: 3.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.